Skip to main content

Table 2 Treatment response

From: The association of immune-inflammation indices at multiple time points with treatment response and survival in advanced non-small cell lung cancer patients receiving immune checkpoint inhibitors

Items

Patients (N = 102)

Best response, n (%)

 

 CR

2 (2.0)

 PR

24 (23.5)

 SD

55 (53.9)

 PD

21 (20.6)

ORR, n (%)

26 (25.5)

DCR, n (%)

81 (79.4)

  1. CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us